AGIOS PHARMACEUTICALS INC's ticker is AGIO and the CUSIP is 00847X104. A total of 162 filers reported holding AGIOS PHARMACEUTICALS INC in Q4 2022. The put-call ratio across all filers is 0.75 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2023 | $4,095,384 | -71.0% | 144,611 | -76.5% | 0.02% | -72.4% |
Q1 2023 | $14,115,823 | +7.2% | 614,533 | +31.1% | 0.09% | -2.2% |
Q4 2022 | $13,162,388 | -4.4% | 468,746 | -3.7% | 0.09% | -18.3% |
Q3 2022 | $13,765,000 | +56.4% | 486,726 | +22.6% | 0.11% | +60.3% |
Q2 2022 | $8,802,000 | -35.1% | 397,015 | -14.8% | 0.07% | -25.3% |
Q1 2022 | $13,561,000 | +33.9% | 465,852 | +51.2% | 0.09% | +33.8% |
Q4 2021 | $10,125,000 | -27.5% | 308,041 | +1.8% | 0.07% | -27.7% |
Q3 2021 | $13,963,000 | +16.2% | 302,547 | +38.8% | 0.09% | +16.0% |
Q2 2021 | $12,015,000 | +14.5% | 218,022 | +7.3% | 0.08% | 0.0% |
Q1 2021 | $10,497,000 | +107.8% | 203,276 | +74.4% | 0.08% | +84.1% |
Q4 2020 | $5,052,000 | +5.9% | 116,586 | -14.5% | 0.04% | -10.2% |
Q3 2020 | $4,770,000 | +101.8% | 136,287 | +208.4% | 0.05% | +88.5% |
Q2 2020 | $2,364,000 | +166.8% | 44,197 | +185.1% | 0.03% | +62.5% |
Q4 2017 | $886,000 | -78.6% | 15,500 | -80.3% | 0.02% | -78.4% |
Q3 2016 | $4,148,000 | +198.4% | 78,537 | +136.6% | 0.07% | +155.2% |
Q2 2016 | $1,390,000 | – | 33,190 | – | 0.03% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Rock Springs Capital Management LP | 3,057,869 | $86,477,000 | 2.23% |
Eagle Health Investments LP | 329,713 | $9,324,000 | 2.14% |
Bellevue Group AG | 4,058,792 | $114,783,000 | 1.65% |
SUVRETTA CAPITAL MANAGEMENT, LLC | 959,214 | $27,127,000 | 1.13% |
ARMISTICE CAPITAL, LLC | 1,924,000 | $54,411,000 | 0.94% |
Integral Health Asset Management, LLC | 100,000 | $2,828,000 | 0.55% |
Monarch Partners Asset Management LLC | 57,820 | $1,635,000 | 0.49% |
ArrowMark Colorado Holdings LLC | 1,380,389 | $39,037,000 | 0.48% |
AlphaCentric Advisors LLC | 15,000 | $424,000 | 0.44% |
PDT Partners, LLC | 72,778 | $2,058,000 | 0.31% |